share_log

賽生藥業:根據收購守則規則3.8刊發的公告

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

香港交易所 ·  Apr 12 10:29
Summary by Moomoo AI
賽生藥業控股有限公司於2024年4月12日宣布,其購股權激勵計劃下授出的254,000份購股權及首次公開發售後購股權計劃下授出的54,500份購股權已經被行使。此舉導致公司新增54,500股新股份,使得公司的已發行股份總數達到627,802,732股。此外,公司目前共有69,801,772份購股權未被行使,其中包括購股權激勵計劃和首次公開發售後購股權計劃下的購股權。公司提醒股東及潛在投資者,關於私有化的建議、計劃及購股權要約的實行仍須待條件達成或獲豁免後方可進行,並建議在買賣公司證券時應謹慎行事。
賽生藥業控股有限公司於2024年4月12日宣布,其購股權激勵計劃下授出的254,000份購股權及首次公開發售後購股權計劃下授出的54,500份購股權已經被行使。此舉導致公司新增54,500股新股份,使得公司的已發行股份總數達到627,802,732股。此外,公司目前共有69,801,772份購股權未被行使,其中包括購股權激勵計劃和首次公開發售後購股權計劃下的購股權。公司提醒股東及潛在投資者,關於私有化的建議、計劃及購股權要約的實行仍須待條件達成或獲豁免後方可進行,並建議在買賣公司證券時應謹慎行事。
SESONG PHARMACEUTICAL HOLDINGS LIMITED ANNOUNCED ON 12 APRIL 2024 THAT 254,000 SHARE OPTIONS GRANTED UNDER ITS SHARE OPTION INCENTIVE PROGRAM AND 54,500 SHARES GRANTED UNDER ITS INITIAL PUBLIC OFFERING POST-RELEASE SHARE OPTION SCHEME HAVE BEEN EXERCISED. The move resulted in the company adding 54,500 new shares, bringing the company's total issued shares to 627,802,732 shares. In addition, the Company currently has a total of 69,801,772 share options unexercised, including those under the Share Option Incentive Scheme and the Initial Public Offering Possession Option Scheme. The Company reminds shareholders and potential investors that the implementation of privatization proposals, plans and share purchase agreements is subject to conditions or exemptions, and recommends that caution should be exercised when buying and selling the Company's securities.
SESONG PHARMACEUTICAL HOLDINGS LIMITED ANNOUNCED ON 12 APRIL 2024 THAT 254,000 SHARE OPTIONS GRANTED UNDER ITS SHARE OPTION INCENTIVE PROGRAM AND 54,500 SHARES GRANTED UNDER ITS INITIAL PUBLIC OFFERING POST-RELEASE SHARE OPTION SCHEME HAVE BEEN EXERCISED. The move resulted in the company adding 54,500 new shares, bringing the company's total issued shares to 627,802,732 shares. In addition, the Company currently has a total of 69,801,772 share options unexercised, including those under the Share Option Incentive Scheme and the Initial Public Offering Possession Option Scheme. The Company reminds shareholders and potential investors that the implementation of privatization proposals, plans and share purchase agreements is subject to conditions or exemptions, and recommends that caution should be exercised when buying and selling the Company's securities.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more